UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3001
Harmony Gold Mining
HMY
$10.8B
| $14.7M | ﹤0.01% |
966,883
+585,889
| +154% | +$9.7M |
2014 Q4
46 quarters
|
|
3002
Carlyle Secured Lending
CGBD
$769M
| $14.7M | ﹤0.01% |
1,395,189
+158,636
| +13% | +$1.77M |
2017 Q2
36 quarters
|
|
3003
AbCellera Biologics
ABCL
$3.85B
| $14.7M | ﹤0.01% |
1,870,633
-2,338,419
| -56% | -$11.4M |
2023 Q4
10 quarters
|
|
3004
Simmons First National
SFNC
$3.37B
| $14.7M | ﹤0.01% |
647,261
-508,622
| -44% | -$10.8M |
2014 Q4
46 quarters
|
|
3005
CALL
Expedia Group
EXPE
$31.1B
| $14.7M | ﹤0.01% |
57,286
-2,114
| -4% | -$502K |
2019 Q3
27 quarters
|
|
3006
GigaCloud Technology
GCT
$2.08B
| $14.7M | ﹤0.01% |
463,830
+78,880
| +20% | +$3.11M |
2023 Q2
12 quarters
|
|
3007
Douglas Emmett
DEI
$1.7B
| $14.6M | ﹤0.01% |
1,239,174
+927,024
| +297% | +$10.4M |
2014 Q4
46 quarters
|
|
3008
SSR Mining
SSRM
$5.66B
| $14.6M | ﹤0.01% |
516,804
+223,286
| +76% | +$6.8M |
2017 Q3
35 quarters
|
|
3009
Vanguard Ultra-Short Treasury ETF
VGUS
$1.08B
| $14.6M | ﹤0.01% |
193,087
+38,920
| +25% | +$2.94M |
2025 Q2
4 quarters
|
|
3010
Takeda Pharmaceutical
TAK
$67.2B
| $14.6M | ﹤0.01% |
911,319
-1,828,910
| -67% | -$30.3M |
2018 Q4
30 quarters
|
|
3011
iShares US Basic Materials ETF
IYM
$1.27B
| $14.6M | ﹤0.01% |
81,336
+391
| +0.5% | +$71.6K |
2014 Q4
46 quarters
|
|
3012
LCI Industries
LCII
$2.38B
| $14.6M | ﹤0.01% |
137,544
+1,868
| +1% | +$205K |
2014 Q4
46 quarters
|
|
3013
PUT
Danaher
DHR
$162B
| $14.6M | ﹤0.01% |
76,400
+16,900
| +28% | +$3.07M |
2018 Q1
33 quarters
|
|
3014
Amplify International Enhanced Dividend Income ETF
IDVO
$1.34B
| $14.5M | ﹤0.01% |
346,337
+8,412
| +2% | +$356K |
2024 Q2
8 quarters
|
|
3015
CALL
Lockheed Martin
LMT
$131B
| $14.5M | ﹤0.01% |
28,524
+6,024
| +27% | +$3.26M |
2022 Q2
16 quarters
|
|
3016
PUT
eBay
EBAY
$53.5B
| $14.5M | ﹤0.01% |
130,000
| – | – |
2024 Q1
9 quarters
|
|
3017
Medical Properties Trust
MPT
$1.08B
| $14.5M | ﹤0.01% |
3,142,032
+426,501
| +16% | +$2.11M |
2014 Q4
46 quarters
|
|
3018
ICU Medical
ICUI
$4.3B
| $14.5M | ﹤0.01% |
99,012
-15,126
| -13% | -$1.97M |
2014 Q4
46 quarters
|
|
3019
Legend Biotech
LEGN
$4.55B
| $14.5M | ﹤0.01% |
502,466
+197,252
| +65% | +$5.32M |
2020 Q2
24 quarters
|
|
3020
Descartes Systems
DSGX
$8.04B
| $14.5M | ﹤0.01% |
209,325
-138,544
| -40% | -$9.9M |
2018 Q3
31 quarters
|
|
3021
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$535M
| $14.4M | ﹤0.01% |
130,332
-2,247
| -2% | -$229K |
2014 Q4
46 quarters
|
|
3022
Asana
ASAN
$2.43B
| $14.4M | ﹤0.01% |
2,063,943
-378,316
| -15% | -$2.54M |
2020 Q3
23 quarters
|
|
3023
First Majestic Silver
AG
$7.48B
| $14.4M | ﹤0.01% |
851,560
-527,282
| -38% | -$10.4M |
2014 Q4
46 quarters
|
|
3024
BBB Foods
TBBB
$7.91B
| $14.4M | ﹤0.01% |
346,243
-91,968
| -21% | -$3.51M |
2024 Q2
8 quarters
|
|
3025
FIVE9
FIVN
$2.1B
| $14.4M | ﹤0.01% |
676,362
-208,532
| -24% | -$4.12M |
2016 Q3
39 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.